Your browser doesn't support javascript.
loading
Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
Hull, Mark A; Ow, Pei Loo; Ruddock, Sharon; Brend, Tim; Smith, Alexandra F; Marshall, Helen; Song, Mingyang; Chan, Andrew T; Garrett, Wendy S; Yilmaz, Omer; Drew, David A; Collinson, Fiona; Cockbain, Andrew J; Jones, Robert; Loadman, Paul M; Hall, Peter S; Moriarty, Catherine; Cairns, David A; Toogood, Giles J.
Afiliação
  • Hull MA; Leeds Institute of Medical Research, University of Leeds, Leeds, UK m.a.hull@leeds.ac.uk.
  • Ow PL; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Ruddock S; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Brend T; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
  • Smith AF; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Marshall H; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Song M; Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
  • Chan AT; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Garrett WS; Harvard TH Chan School of Public Health, Boston, Massachusetts, USA.
  • Yilmaz O; Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology, Boston, Massachusetts, USA.
  • Drew DA; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Collinson F; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Cockbain AJ; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Jones R; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Loadman PM; Institute of Cancer Therapeutics, University of Bradford, Bradford, UK.
  • Hall PS; Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.
  • Moriarty C; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Cairns DA; Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Toogood GJ; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
BMJ Open ; 13(11): e077427, 2023 11 29.
Article em En | MEDLINE | ID: mdl-38030258
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: BMJ Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido